BCAX- Bicara Therapeutics Inc.
Bicara Therapeutics Inc. (BCAX) has 5 insiders with recent SEC Form 4 filings, including 0 buys and 15 sells. BCAX is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 377.2K | $8.76M | - | |
| COO | 191.6K | $4.45M | - | |
| CFO | 125.0K | $2.90M | - | |
| Other | 90.0K | $2.09M | - | |
| Other | 60.8K | $1.41M | - |
Activity
Buys and sells only
Transactions
10 filings
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 15, 2026 | Cohlhepp Ryan52 | President And COO | Sale+OE | 12,500 | $20.29 | $253,648.75 | -3.1% | - | - | |
| Apr 27, 2026 | Raben David58 | Chief Medical Officer | Sale+OE | 5,500 | $22.88 | $125,830.10 | -9.0% | - | - | |
| Apr 20, 2026 | Mazumdar Claire52 | Chief Executive Officer | Sale+OE | 15,000 | $23.61 | $354,145.50 | -4.0% | - | - | |
| Mar 25, 2026 | Raben David58 | Chief Medical Officer | Sale+OE | 5,500 | $18.95 | $104,229.40 | -9.0% | +24.4% | - | |
| Mar 20, 2026 | Mazumdar Claire52 | Chief Executive Officer | Sale+OE | 15,000 | $18.82 | $282,365.69 | -1.5% | +26.2% | - | |
| Mar 16, 2026 | Cohlhepp Ryan52 | President And COO | Sale+OE | 12,500 | $19.66 | $245,713.75 | -3.0% | +11.8% | - | |
| Mar 9, 2026 | Mazumdar Claire52 | Chief Executive Officer | Sale+OE | 36,766 | $19.17 | $704,657.16 | -9.8% | +1.6% | - | |
| Jan 15, 2026 | Cohlhepp Ryan52 | President And COO | Sell | 149 | $18.02 | $2,684.98 | - | +26.5% | - | |
| Dec 22, 2025 | Hyep Ivan62 | Chief Financial Officer | Sale+OE | 9,200 | $18.31 | $168,491.56 | -6.0% | +0.4% | - | |
| Dec 15, 2025 | Cohlhepp Ryan52 | President And COO | Sale+OE | 12,500 | $18.68 | $233,547.50 | -3.2% | +5.7% | - |
Page 1Next →